Annual Non Current Assets
$22.73 M
+$1.72 M+8.18%
December 31, 2023
Summary
- As of February 8, 2025, KROS annual long term assets is $22.73 million, with the most recent change of +$1.72 million (+8.18%) on December 31, 2023.
- During the last 3 years, KROS annual non current assets has risen by +$21.02 million (+1223.94%).
- KROS annual non current assets is now at all-time high.
Performance
KROS Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$27.23 M
+$4.92 M+22.04%
September 30, 2024
Summary
- As of February 8, 2025, KROS quarterly long term assets is $27.23 million, with the most recent change of +$4.92 million (+22.04%) on September 30, 2024.
- Over the past year, KROS quarterly non current assets has increased by +$4.49 million (+19.77%).
- KROS quarterly non current assets is now at all-time high.
Performance
KROS Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
KROS Non Current Assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +8.2% | +19.8% |
3 y3 years | +1223.9% | +600.2% |
5 y5 years | +1108.5% | - |
KROS Non Current Assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +496.5% | at high | +614.4% |
5 y | 5-year | at high | +1223.9% | at high | +1485.6% |
alltime | all time | at high | +1223.9% | at high | +1485.6% |
Keros Therapeutics Non Current Assets History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $27.23 M(+22.0%) |
Jun 2024 | - | $22.31 M(-1.7%) |
Mar 2024 | - | $22.69 M(-0.2%) |
Dec 2023 | $347.29 M(+21.5%) | $22.73 M(+4.2%) |
Sep 2023 | - | $21.81 M(-0.8%) |
Jun 2023 | - | $22.00 M(-1.0%) |
Mar 2023 | - | $22.21 M(+5.7%) |
Dec 2022 | $285.77 M | $21.01 M(+214.8%) |
Sep 2022 | - | $6.67 M(+55.1%) |
Jun 2022 | - | $4.30 M(+9.7%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | $3.92 M(+2.9%) |
Dec 2021 | $251.44 M(-6.1%) | $3.81 M(-2.0%) |
Sep 2021 | - | $3.89 M(+90.2%) |
Jun 2021 | - | $2.04 M(+16.9%) |
Mar 2021 | - | $1.75 M(+1.8%) |
Dec 2020 | $267.73 M(+2899.1%) | $1.72 M(-6.2%) |
Sep 2020 | - | $1.83 M(-4.7%) |
Jun 2020 | - | $1.92 M(-6.4%) |
Mar 2020 | - | $2.05 M(+1.2%) |
Dec 2019 | $8.93 M(-65.0%) | $2.03 M |
Dec 2018 | $25.53 M | - |
FAQ
- What is Keros Therapeutics annual long term assets?
- What is the all time high annual non current assets for Keros Therapeutics?
- What is Keros Therapeutics annual non current assets year-on-year change?
- What is Keros Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for Keros Therapeutics?
- What is Keros Therapeutics quarterly non current assets year-on-year change?
What is Keros Therapeutics annual long term assets?
The current annual non current assets of KROS is $22.73 M
What is the all time high annual non current assets for Keros Therapeutics?
Keros Therapeutics all-time high annual long term assets is $22.73 M
What is Keros Therapeutics annual non current assets year-on-year change?
Over the past year, KROS annual long term assets has changed by +$1.72 M (+8.18%)
What is Keros Therapeutics quarterly long term assets?
The current quarterly non current assets of KROS is $27.23 M
What is the all time high quarterly non current assets for Keros Therapeutics?
Keros Therapeutics all-time high quarterly long term assets is $27.23 M
What is Keros Therapeutics quarterly non current assets year-on-year change?
Over the past year, KROS quarterly long term assets has changed by +$4.49 M (+19.77%)